A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure

NCT04244591 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

NCT04847622 ·Status: COMPLETED

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

NCT04547140 ·Status: TERMINATED ·Phase: PHASE2

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

NCT05195749 ·Status: TERMINATED ·Phase: PHASE2

Collection of Anti-SARS-CoV-2 Immune Plasma

NCT04344977 ·Status: COMPLETED

Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

NCT05045937 ·Status: UNKNOWN

A Registry Study of Patients Hospitalized With Confirmed COVID-19

NCT05792865 ·Status: UNKNOWN

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

NCT05459532 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

NCT05689034 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

NCT05595369 ·Status: COMPLETED ·Phase: PHASE2

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

NCT05715528 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04745351 ·Status: TERMINATED ·Phase: PHASE3

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

NCT05305547 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

NCT05438602 ·Status: COMPLETED ·Phase: PHASE2

A Study of S-892216 in Participants With COVID-19

NCT06928051 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

NCT05532852 ·Status: UNKNOWN ·Phase: NA

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

NCT05545319 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

NCT05398705 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

NCT04545047 ·Status: COMPLETED

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

NCT05567952 ·Status: COMPLETED ·Phase: PHASE2

A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

NCT04657497 ·Status: COMPLETED ·Phase: PHASE3

Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

NCT04292340 ·Status: UNKNOWN

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT06667700 ·Status: RECRUITING ·Phase: PHASE3

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

NCT05697055 ·Status: UNKNOWN ·Phase: PHASE4

Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

NCT04259892 ·Status: COMPLETED